Status:
COMPLETED
Comparison of the Effects of Two Frequencies of Application of Photobiomodulation on Facial Rejuvenation
Lead Sponsor:
University of Nove de Julho
Conditions:
Wrinkle
Facial Expression
Eligibility:
FEMALE
45-60 years
Phase:
NA
Brief Summary
Skin aging is an irreversible, slow and progressive process, being influenced mainly by age, but also by external factors such as ultraviolet radiation, smoking, alcohol, among others. Studies have sh...
Eligibility Criteria
Inclusion
- Female volunteers aged 45 to 60 years;
- At menopause (at least 12 months without menstruation);
- Healthy;
- Skin phototype I to IV by Fitzpatrick classification;
- Visible signs of skin aging grades III and IV of the Glogau scale.
Exclusion
- With a history of photosensitivity.
- Who have any type of lesion on the skin of the face.
- Who use corticosteroids, anticoagulants, or any drug known to increase photosensitivity, including systemic retinoids and use of topical retinoic acid in the last 6 months.
- People with any collagen-related diseases, malnutrition, anemia, immunosuppression, cancer diseases, smokers, predisposition to hypertrophic and keloid scarring, history of dermatological diseases, surgery on the face, trauma to the face, diseases that could affect the condition of the skin and disease psychiatric.
- Who are in the menstrual period, in the climacteric or in hormone replacement therapy.
- Who underwent cosmetic procedures on the face, such as application of botulinum toxin in the last 8 months, facial filling in the last year, chemical peels, ablative laser and dermabrasion in the last 6 months.
- Who do not respect the post treatment recommendations or who fail to attend a treatment session.
- Those that, during the procedures, present any type of complication (hypersensitivity, allergies) will not be part of the statistical analysis, as these cases will not be in the expected pattern for these procedures. However, these data will be described and discussed, as well as the possible adverse effects and the participants will receive treatment to resolve the condition
Key Trial Info
Start Date :
May 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2023
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT04911140
Start Date
May 30 2021
End Date
December 10 2023
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nove de Julho University
São Paulo, São Paulo, Brazil, 01525-000